Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wisconsin Business Press.
Press releases published on August 26, 2025
LifeStance to Present at the 23rd Annual Morgan Stanley Healthcare Conference
SCOTTSDALE, Ariz., Aug. 26, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, today announced that management will present at the upcoming 23rd Annual Morgan …
MYR Group Inc. Announces Appointment of New Board Member
THORNTON, Colo., Aug. 26, 2025 (GLOBE NEWSWIRE) -- MYR Group Inc. (“MYR Group” or the “Company”) (NASDAQ: MYRG), announced today the appointment of Aurelie Richard to the Company’s Board of Directors (the “Board”), effective August 26, 2025. Ms. Richard …
Vera Therapeutics to Participate at Upcoming Investor Conferences
BRISBANE, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, …
StepStone Group to Present at the Barclays Global Financial Services Conference
NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- StepStone Group Inc. (Nasdaq: STEP) today announced that Scott Hart, CEO, and Mike McCabe, Head of Strategy, are scheduled to present at the Barclays Global Financial Services Conference on Tuesday, September 9, …
Pulmonx to Participate in September Investor Conferences
REDWOOD CITY, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced that management will present at the following …
Zentalis Pharmaceuticals Appoints James B. Bucher, JD, as Chief Legal Officer and Corporate Secretary
SAN DIEGO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other …
Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date August 15, 2025
NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- At the end of the settlement date of August 15, 2025, short interest in 3,302 Nasdaq Global MarketSM securities totaled 13,965,671,937 shares compared with 13,683,072,188 shares in 3,285 Global Market issues …
nCino Reports Second Quarter Fiscal Year 2026 Financial Results
Total Revenues of $148.8M, up 12% year-over-year Subscription Revenues of $130.8M, up 15% year-over-year WILMINGTON, N.C., Aug. 26, 2025 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking solutions, …
Sana Biotechnology to Present at September 2025 Investor Conferences
SEATTLE, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at four investor conferences in …
Seer to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
REDWOOD CITY, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that the company will be participating in the upcoming Morgan Stanley 23rd Annual …
Consumer Portfolio Services to Present at the 2025 Gateway Conference on September 3rd
LAS VEGAS, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Consumer Portfolio Services, Inc. (Nasdaq: CPSS) (“CPS” or the “Company”), a leader in providing indirect automobile financing to consumers, is confirmed to present at the 2025 Annual Gateway Conference, which …
Lesaka to Host Webcast and Conference Call to Review Fourth Quarter and Year-End 2025 Results on September 11, 2025
JOHANNESBURG, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Lesaka Technologies, Inc. (NASDAQ:LSAK, JSE: LSK) ("Lesaka") now intends to release fourth quarter and year-end 2025 results after the U.S. market close on September 10, 2025. Lesaka management will host a …
Immuneering Announces Closing of $25 Million Private Placement
CAMBRIDGE, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer patients alive, today announced the closing of its previously announced private placement. The private …
Calavo Growers to Report Third Quarter 2025 Financial Results
SANTA PAULA, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Calavo Growers, Inc. (Nasdaq-GS: CVGW), a global leader in sourcing, packing and distribution of fresh avocados, tomatoes, papayas and processing of guacamole and other avocado products, today …
iMDx to Participate in NYC Investment Conferences September 8 - 11
NASHVILLE, Tenn., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., or iMDx, (Nasdaq: IMDX), today announced participation in investor conferences hosted by both H.C. Wainwright and Lake Street Capital Markets. Information for each can …
3D Systems Receives $7.65 Million Contract Award from U.S. Air Force for Advanced Metal Printing System
Two-year contract award for Large-format Metal 3D Printer Advanced Technology Demonstrator Supports development of large-scale industrial metal AM print capabilities for high-speed flight applications Award is an extension of an existing program to …
IRADIMED CORPORATION to Participate in the 2025 Wells Fargo Healthcare Conference
ORLANDO, Fla., Aug. 26, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in innovative medical devices for Magnetic Resonance Imaging (“MRI”) compatible patient monitoring and infusion systems, today announced that it will participate …
NovaBay Pharmaceuticals Announces One-Time Special Cash Dividend of $0.80 Per Share
EMERYVILLE, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces its Board of Directors and the Special Transaction Committee of the Board of Directors has declared a one-time …
Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference
MENLO PARK, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company) an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform …